- Home
- QNCX vs TNYA Comparison
QNCX vs TNYA Comparison
Compare QNCX & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | TNYA |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 157.9M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QNCX | TNYA |
|---|---|---|
| Price | $3.06 | $0.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $7.67 | $5.25 |
| AVG Volume (30 Days) | 979.1K | ★ 2.9M |
| Earning Date | 11-12-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $0.36 |
| 52 Week High | $4.55 | $2.35 |
Technical Indicators
Market Signals| Indicator | QNCX | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 40.19 |
| Support Level | $2.85 | $0.67 |
| Resistance Level | $3.72 | $0.79 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 41.38 | 40.75 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.